Importance of Clinical Trials with Multiple Myeloma: A Patient’s Journey

Multiple myeloma is the second most commonly diagnosed blood cancer, after non-Hodgkin’s Lymphoma, yet few people know much about this deadly disease.

Our goal right now, is to develop sequential, effective treatments that we use in the wisest order, somewhat like having different beads in chain, and making those beads longer for each one, making more beads in the chain so that patients can achieve a long life, with a good quality of life when they are participating in each bead.

To learn more about multiple myeloma, consult with your physician and visit these links below.

Dr. Donna Reece, Princess Margaret Cancer Centre image

Dr. Donna Reece
Director, Multiple Myeloma and Related Diseases,
Princess Margaret Cancer Centre 

This health education initiative was supported by Princess Margaret Cancer Centre.